IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,129 | +63.5% | 2,446 | +152.9% | 0.00% | – |
| Q2 2023 | $6,808 | +289.7% | 967 | +238.1% | 0.00% | – |
| Q1 2023 | $1,747 | +74.7% | 286 | +460.8% | 0.00% | – |
| Q2 2022 | $1,000 | -92.9% | 51 | -94.0% | 0.00% | – |
| Q1 2022 | $14,000 | +16.7% | 847 | +36.6% | 0.00% | – |
| Q4 2021 | $12,000 | -20.0% | 620 | +5.3% | 0.00% | -100.0% |
| Q3 2021 | $15,000 | +87.5% | 589 | +86.4% | 0.00% | – |
| Q2 2021 | $8,000 | +100.0% | 316 | +156.9% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 123 | +151.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |